Chemotherapy-induced peripheral neuropathy: Identifying the research gaps and associated changes to clinical trial design.

To the authors' knowledge, very little of the mechanistic understanding of the development of CIPN is being translated into intervention rationale in clinical trials that evaluate interventions to mitigate CIPN. Efforts to incentivize this translation are needed.